Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
The Perspectives of Iranian Patients With Multiple Sclerosis on Continuity of Care: A Qualitative Study.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
Exploring the Role of Nerve Growth Factorin Multiple Sclerosis: Implications in Myelin Repair.
FTY720 for cancer therapy (Review).
Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica.
Epilepsy surgery outcome in temporal lobe cavernoma and multiple sclerosis.
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?
Risk evaluation and monitoring in multiple sclerosis therapeutics.
Managed care aspects of managing neurogenic bladder/neurogenic detrusor overactivity.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
The multiple sclerosis self-management scale: clinicometric testing.
The central role of mitochondria in axonal degeneration in multiple sclerosis.
MRI in the Evaluation of Acute Visual Syndromes.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Saturable Leptin Transport Across the BBB Persists in EAE Mice.
Neurological diseases in pregnancy.
Sleep-disordered breathing in multiple sclerosis.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
Vitamin D3 potentiates myelination and recovery after facial nerve injury.
Pages
« first
‹ previous
…
451
452
453
454
455
456
457
458
459
…
next ›
last »